Report overview
Genomics is science that studies the composition of biological genomes, the precise structure, interrelationships, and expression regulation of genes in a genome. In genomics, scientists analyze the genomic information of biological samples (tissue, cells, blood samples, etc.) using a novel gene sequencer.
Generation sequencing technology has been developed for 40 years. According to different sequencing principles, gene sequencing technology has been divided into three generations: the first generation of gene sequencing Sanger Sequencing, the second generation of gene sequencing NGS (Next Generation Sequencing), the third generation of gene sequencing TGS.
Next Generation Sequencing (NGS) is a high-throughput method for rapid sequencing of base pairs of DNA or RNA samples. Next generation sequencing systems can be divided by three parts, instruments, consumables and related services. At the same time, NGS also supports a wide range of applications, including gene expression profiling, chromosome counting, epigenetic change detection, and molecular analysis, which can drive discovery research and realize the bright future of personalized medicine.
This report aims to provide a comprehensive presentation of the global market for Next Generation Sequencing (NGS) Product, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Next Generation Sequencing (NGS) Product. This report contains market size and forecasts of Next Generation Sequencing (NGS) Product in global, including the following market information:
Global Next Generation Sequencing (NGS) Product Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Next Generation Sequencing (NGS) Product market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Consumables and Reagents Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Next Generation Sequencing (NGS) Product include Illumina, Thermo Fisher Scientific, BGI, LabCorp, Roche, PerkinElmer, Eurofins Scientific, New England Biolabs and Mgi Tech, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Next Generation Sequencing (NGS) Product companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Next Generation Sequencing (NGS) Product Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Next Generation Sequencing (NGS) Product Market Segment Percentages, by Type, 2022 (%)
Consumables and Reagents
Instruments
Others
Global Next Generation Sequencing (NGS) Product Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Next Generation Sequencing (NGS) Product Market Segment Percentages, by Application, 2022 (%)
Life Science
Traslational Medicine & Pharma
Others
Global Next Generation Sequencing (NGS) Product Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Next Generation Sequencing (NGS) Product Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Next Generation Sequencing (NGS) Product revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Next Generation Sequencing (NGS) Product revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Illumina
Thermo Fisher Scientific
BGI
LabCorp
Roche
PerkinElmer
Eurofins Scientific
New England Biolabs
Mgi Tech
Agilent Technologies
Promega
Natera
Norgen Biotek
LifeCodexx
Amoy Diagnostics
BioCat GmbH
Rightongene Biotechnology
Kindstar Global
CoWin Biotech
Berrygenomics
Capitalbio
QIAGEN
Annaroad Gene Technology
Find Biotechnology
Daan Gene
Novogene
Omixon
Swift Biosciences
NimaGen
Outline of Major Chapters:
Chapter 1: Introduces the definition of Next Generation Sequencing (NGS) Product, market overview.
Chapter 2: Global Next Generation Sequencing (NGS) Product market size in revenue.
Chapter 3: Detailed analysis of Next Generation Sequencing (NGS) Product company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Next Generation Sequencing (NGS) Product in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
